2025 Spring Meeting and 21st Global Congress on Process Safety April 6-10, 2025 Hilton Anatole, Dallas, TX
2025 AIChE Annual Meeting November 2-6, 2025 John B. Hynes Veterans Memorial Convention Center, Marriott Copley Place, Sheraton Back Bay | Boston, MA
Archived Webinar Want to be an Entrepreneur? Personal Stories From Three Successful Entrepreneurs Who Have Traveled This Path.
David Roush Citation name Roush, D. Affiliation Merck & Company, Inc. State NJ Country USA Authored(515ar) Development Of A Streamlined Process For Efficient Purification Of Reverse Chimeric (Murine IgG1) Monoclonal AntibodiesBruno MarquesDavid Roush2007 Annual Meeting (148c) Evaluation Of Solvent Resistant Nanofiltration As An Alternative To Distillation In The Isolation Of An Active Pharmaceutical IntermediateJennifer M. PollardKent E. GoklenDavid Roush2007 Annual Meeting (233d) Characterization of Monoclonal Antibody Primary Recovery and Purification Steps: Towards Process ValidationMichael IammarinoNihal TugcuJoseph Nti-GyabaahMartin ChandlerDavid Roush2009 Annual Meeting (215b) Impact of virus filtration load handling on virus filter performanceHong LiDarshini ShahKathleen McLaughlinMichael IammarinoDavid RoushNihal Tugcu2015 AIChE Annual Meeting Proceedings (ISBN: 978-0-8169-1094-6) Associated proceedings 2007 Annual Meeting 2009 Annual Meeting 2015 AIChE Annual Meeting Proceedings
